E3

Tissue-Agnostic Medicine Has a New Proof Point

Lung Cancer May Be Entering the Chemo-Replacement Fight

A Blood Test Can See Risk. Policy Cannot Yet Hold It.

AI can flag hidden cardiac risk. The dangerous part is what health systems do next

Metabolic syndrome may leave a signature in mitochondrial DNA. The biomarker race should not outrun the evidence

Breast Cancer Gets a New PI3K Pathway Option.

Bladder Cancer Surgery Just Became a System Test

Beans for men, broccoli for women? The real cardiometabolic warning is that risk starts by 22

Radioligand Therapy Is Building Its Evidence Base. Now Build the Infrastructure.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
